SEC 13F Intelligence

Western Financial Corp / ARWR

Western Financial Corp’s Arrowhead Pharmaceuticals In Position

Does Western Financial Corp own Arrowhead Pharmaceuticals In (ARWR)? Yes — 820.3K shares worth $27M (+18.96% of its 13F portfolio) as of Q3 2022.

Position Value
$27M
Q3 2022
Shares
820.3K
% of Portfolio
+18.96%
Quarters Held
8
currently held

Position History ARWR

Reported value by quarter
Q4 ’20: $63MQ4 ’20Q1 ’21: $54MQ1 ’21Q2 ’21: $68MQ2 ’21Q3 ’21: $51MQ3 ’21Q4 ’21: $54MQ4 ’21Q1 ’22: $38MQ1 ’22Q2 ’22: $29MQ2 ’22Q3 ’22: $27MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022820.3K$27M+18.96%
Q2 2022820.3K$29M+20.53%
Q1 2022820.3K$38M+21.90%
Q4 2021820.3K$54M+28.54%
Q3 2021820.3K$51M+30.37%
Q2 2021820.3K$68M+36.71%
Q1 2021820.3K$54M+33.22%
Q4 2020820.3K$63M+41.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Western Financial Corp’s full portfolio or all institutional holders of ARWR.